quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:36:56·784d
NEWSRelease
Computer Programs and Systems Inc. logo

Computer Programs And Systems, Inc. Sees Q1 Revenue $82M-$84M vs $87.44M Est., FY24 Revenue $340M-$350M vs $345.29M Est.

CPSI· Computer Programs and Systems Inc.
Technology
Original source

Companies

  • CPSI
    Computer Programs and Systems Inc.
    Technology

Recent analyst ratings

  • Jan 3UpdateBarclays$12.00
  • Aug 15UpdateCantor Fitzgerald$24.00
  • Apr 12UpdateStephens$30.00
  • Mar 4UpdateDeutsche Bank$39.00
  • Mar 3UpdateSVB Leerink$38.00
  • Feb 16UpdateSVB Leerink$35.00

Related

  • INSIDER773d
    Cronkite Wes covered exercise/tax liability with 1,456 shares, decreasing direct ownership by 7% to 20,589 units (SEC Form 4)
  • INSIDER773d
    Dye David A covered exercise/tax liability with 3,019 shares, decreasing direct ownership by 4% to 65,721 units (SEC Form 4)
  • INSIDER773d
    Plessner Kevin covered exercise/tax liability with 734 shares, decreasing direct ownership by 14% to 4,549 units (SEC Form 4)
  • INSIDER773d
    Severance Dawn M covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 9% to 13,557 units (SEC Form 4)
  • INSIDER773d
    Park Lance covered exercise/tax liability with 339 shares, decreasing direct ownership by 10% to 3,082 units (SEC Form 4)
  • INSIDER773d
    Fowler Christopher L covered exercise/tax liability with 3,733 shares, decreasing direct ownership by 5% to 78,461 units (SEC Form 4)
  • INSIDER776d
    Tobin Glenn bought $84,420 worth of shares (10,500 units at $8.04), increasing direct ownership by 44% to 34,347 units (SEC Form 4)
  • 13D/G778d
    SEC Form SC 13G/A filed by Computer Programs and Systems Inc. (Amendment)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022